Evidence map›Paper›PMID 40478193›Full record

ArticleJournal of cellular and molecular medicine2025

Deciphering Deleterious nsSNPs in MUC16's SEA Domain: Structural and Functional Implications in Cancer Metastasis via Computational Analysis.

Muaz Faruque, Maisha Maliha Medha, A M U B Mahfuz, Md Monirul Islam, Md Afjalus Siraj

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Muaz FaruquePharmacy Discipline, Life Science School, Khulna University, Khulna, Bangladesh.
Maisha Maliha MedhaPharmacy Discipline, Life Science School, Khulna University, Khulna, Bangladesh.
A M U B MahfuzDepartment of Biotechnology and Genetic Engineering, Faculty of Life Science, University of Development Alternative, Dhaka, Bangladesh.
Md Monirul IslamPharmacy Discipline, Life Science School, Khulna University, Khulna, Bangladesh.
Md Afjalus SirajDepartment of Pharmacy, Faculty of Health Sciences, Gono Bishwabidyalay, Dhaka, Bangladesh.ORCID 0000-0002-3242-2633

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MUC16 ranks among the top three genes exhibiting the highest mutation frequencies in various cancer types. It encodes transmembrane mucins present in the epithelial linings of the ocular, respiratory, gastric and female reproductive systems, serving to protect and maintain mucosal surfaces. Overexpression of MUC16 contributes to the differentiation, proliferation, invasion and metastasis of cancer cells in ovarian, endometrial, pancreatic, colon, breast and non-small-cell lung cancers. In this study, we analysed the structural and functional effects of pathogenic and potentially harmful non-synonymous single nucleotide polymorphisms (nsSNPs) of MUC16, employing a blend of computational algorithms. Initially, SNPs data for MUC16 were gathered from the Ensembl database and refined using computational tools (PROVEAN, SIFT, PolyPhen-2, SNAP-2, MutPred, I-Mutant3.0 and MUpro) to isolate four final pathogenic SNP variants (L151P, Y144N, C111Y and D108Y). Through evolutionary conservation analysis, we determined that these mutational variants originate from a highly conserved and stable domain. Our findings particularly emphasise the Y144N variant as a potentially highly deleterious mutation situated in the SEA5 domain. This variant could significantly impact stability, overall flexibility, compactness, expansion, glycosylation ability and metastatic potential when compared to both the wild-type and other mutant variants. In summary, these findings shed light on missense mutational variants, providing insights into the vast array of disease susceptibilities associated with MUC16's glycosylation process. This understanding could aid in the development of effective drugs for diseases linked with these mutations.

Indexed as

CA-125 AntigenComputational BiologyMembrane ProteinsNeoplasmsPolymorphism, Single NucleotideAmino Acid SequenceHumansMutationNeoplasm MetastasisProtein DomainsCA-125 AntigenMembrane ProteinsMUC16 protein, humanglycosylationmetastasisMUC16non‐synonymous single nucleotide polymorphismsPolyPhen‐2

Identifiers

PMID40478193
PMCPMC12143179

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.